Qu Zhibo,Ma Da.Recent advances of stem cell therapy for Hirschsprung’s disease[J].Journal of Clinical Pediatric Surgery,2023,22(12):1197-1201.[doi:10.3760/cma.j.cn101785-202308039-019]
先天性巨结肠干细胞治疗的研究进展
- Title:
- Recent advances of stem cell therapy for Hirschsprung’s disease
- 关键词:
- 干细胞; 治疗; Hirschsprung病; 胚胎发育; 研究
- Keywords:
- Stem Cells; Therapy; Hirschsprung Disease; Embryonic Development; Research
- 摘要:
- 干细胞治疗已在器官修复和组织再生领域发挥重要作用,特别是对某些重大疾病及临床上疑难杂症的治疗和缓解具有重要意义,有较为广阔的应用前景。本文就干细胞治疗先天性巨结肠的可行性与研究进展进行综述。
- Abstract:
- Playing a vital role in the field of organ repair and tissue regeneration,stem cell therapy is indicated for the treatment and remission of some major diseases and difficult diseases.It has a broad range of application prospects.This review summarized the latest researches of stem cell therapy for Hirschsprung’s disease.
参考文献/References:
[1] 翟威,刘远梅.神经嵴细胞迁移障碍在先天性巨结肠发病中的作用研究进展[J].中华小儿外科杂志,2023,44(1):87-91.DOI:10.3760/cma.j.cn421158-20220711-00485. Zhai W,Liu YM.Research advances on the role of neural crest cell migration disorder in Hirschsprung’s disease[J].Chin J Pediatr Surg,2023,44(1):87-91.DOI:10.3760/cma.j.cn421158-20220711-00485.
[2] Bradnock TJ,Knight M,Kenny S,et al.Hirschsprung’s disease in the UK and Ireland:incidence and anomalies[J].Arch Dis Child,2017,102(8):722-727.DOI:10.1136/archdischild-2016-311872.
[3] 曾纪晓,徐晓钢.先天性巨结肠诊疗规范化的再思考[J].临床小儿外科杂志,2021,20(3):201-207.DOI:10.12260/lcxewkzz.2021.03.001. Zeng JX,Xu XG.Some focal issues of standardizing the diagnosis and treatment of Hirschsprung’s disease[J].J Clin Ped Sur,2021,20(3):201-207.DOI:10.12260/lcxewkzz.2021.03.001.
[4] 李颀,张震,李龙.先天性巨结肠再次手术的技术和思考[J].临床小儿外科杂志,2021,20(3):208-211.DOI:10.12260/lcxewkzz.2021.03.002. Li Q,Zhang Z,Li L.Techniques and considerations of re-operations for Hirschsprung’s disease[J].J Clin Ped Sur,2021,20(3):208-211.DOI:10.12260/lcxewkzz.2021.03.002.
[5] 王吉,李智.先天性巨结肠非手术治疗研究进展[J].临床小儿外科杂志,2022,21(2):186-190.DOI:10.3760/cma.j.cn.101785-202104064-016. Wang J,Li Z.Recent advances of non-surgical treatment of Hirschsprung’s disease[J].J Clin Ped Sur,2022,21(2):186-190.DOI:10.3760/cma.j.cn.101785-202104064-016.
[6] Shellard A,Mayor R.Integrating chemical and mechanical signals in neural crest cell migration[J].Curr Opin Genet Dev,2019,57:16-24.DOI:10.1016/j.gde.2019.06.004.
[7] Schriemer D,Sribudiani Y,IJpma A,et al.Regulators of gene expression in enteric neural crest cells are putative Hirschsprung disease genes[J].Dev Biol,2016,416(1):255-265.DOI:10.1016/j.ydbio.2016.06.004.
[8] Gui HS,Schriemer D,Cheng WW,et al.Whole exome sequencing coupled with unbiased functional analysis reveals new Hirschsprung disease genes[J].Genome Biol,2017,18(1):48.DOI:10.1186/s13059-017-1174-6.
[9] Szabó A,Mayor R.Mechanisms of neural crest migration[J].Annu Rev Genet,2018,52:43-63.DOI:10.1146/annurev-genet-120417-031559.
[10] Sánchez MP,Silos-Santiago I,Frisén J,et al.Renal agenesis and the absence of enteric neurons in mice lacking GDNF[J].Nature,1996,382(6586):70-73.DOI:10.1038/382070a0.
[11] Ji Y,Tam PKH,Tang CSM.Roles of enteric neural stem cell niche and enteric nervous system development in Hirschsprung disease[J].Int J Mol Sci,2021,22(18):9659.DOI:10.3390/ijms22189659.
[12] Roberto GM,Emery G.Directing with restraint:mechanisms of protrusion restriction in collective cell migrations[J].Semin Cell Dev Biol,2022,129:75-81.DOI:10.1016/j.semcdb.2022.03.037.
[13] Heuckeroth RO,Sch?fer KH.Gene-environment interactions and the enteric nervous system:neural plasticity and Hirschsprung disease prevention[J].Dev Biol,2016,417(2):188-197.DOI:10.1016/j.ydbio.2016.03.017.
[14] Alhawaj AF.Stem cell-based therapy for Hirschsprung disease,do we have the guts to treat?[J].Gene Ther,2022,29(10/11):578-587.DOI:10.1038/s41434-021-00268-4.
[15] Alves MM,Sribudiani Y,Brouwer RWW,et al.Contribution of rare and common variants determine complex diseases-Hirschsprung disease as a model[J].Dev Biol,2013,382(1):320-329.DOI:10.1016/j.ydbio.2013.05.019.
[16] Tilghman JM,Ling AY,Turner TN,et al.Molecular genetic anatomy and risk profile of Hirschsprung’s disease[J].N Engl J Med,2019,380(15):1421-1432.DOI:10.1056/NEJMoa1706594.
[17] Yang DH,Yang J,Li S,et al.Effects of RET,NRG1 and NRG3 polymorphisms in a Chinese population with Hirschsprung disease[J].Sci Rep,2017,7:43222.DOI:10.1038/srep43222.
[18] Kim JH,Cheong HS,Sul JH,et al.A genome-wide association study identifies potential susceptibility loci for Hirschsprung disease[J].PLoS One,2014,9(10):e110292.DOI:10.1371/journal.pone.0110292.
[19] Torroglosa A,Villalba-Benito L,Luzón-Toro B,et al.Epigenetic mechanisms in Hirschsprung disease[J].Int J Mol Sci,2019,20(13):3123.DOI:10.3390/ijms20133123.
[20] Thakkar HS,Bassett C,Hsu A,et al.Functional outcomes in Hirschsprung disease:a single institution’s 12-year experience[J].J Pediatr Surg,2017,52(2):277-280.DOI:10.1016/j.jpedsurg.2016.11.023.
[21] Burns AJ,Thapar N.Neural stem cell therapies for enteric nervous system disorders[J].Nat Rev Gastroenterol Hepatol,2014,11(5):317-328.DOI:10.1038/nrgastro.2013.226.
[22] Obermayr F,Seitz G.Recent developments in cell-based ENS regeneration-a short review[J].Innov Surg Sci,2018,3(2):93-99.DOI:10.1515/iss-2018-0005.
[23] Lai FPL,Lau ST,Wong JKL,et al.Correction of Hirschsprung-associated mutations in human induced pluripotent stem cells via clustered regularly interspaced short palindromic repeats/Cas9,restores neural crest cell function[J].Gastroenterology,2017,153(1):139-153.e8.DOI:10.1053/j.gastro.2017.03.014.
[24] Barber K,Studer L,Fattahi F.Derivation of enteric neuron lineages from human pluripotent stem cells[J].Nat Protoc,2019,14(4):1261-1279.DOI:10.1038/s41596-019-0141-y.
[25] Fattahi F,Steinbeck JA,Kriks S,et al.Deriving human ENS lineages for cell therapy and drug discovery in Hirschsprung disease[J].Nature,2016,531(7592):105-109.DOI:10.1038/nature16951.
[26] Kobayashi GS,Musso CM,de Paula Moreira D,et al.Recapitulation of neural crest specification and EMT via induction from neural plate border-like cells[J].Stem Cell Reports,2020,15(3):776-788.DOI:10.1016/j.stemcr.2020.07.023.
[27] Zhang A,Aslam H,Sharma N,et al.Conservation of epithelial-to-mesenchymal transition process in neural crest cells and metastatic cancer[J].Cells Tissues Organs,2021,210(3):151-172.DOI:10.1159/000516466.
[28] Yang J,Antin P,Berx G,et al.Guidelines and definitions for research on epithelial-mesenchymal transition[J].Nat Rev Mol Cell Biol,2020,21(6):341-352.DOI:10.1038/s41580-020-0237-9.
[29] Piacentino ML,Li YW,Bronner ME.Epithelial-to-mesenchymal transition and different migration strategies as viewed from the neural crest[J].Curr Opin Cell Biol,2020,66:43-50.DOI:10.1016/j.ceb.2020.05.001.
[30] Hotta R,Stamp LA,Foong JPP,et al.Transplanted progenitors generate functional enteric neurons in the postnatal colon[J].J Clin Invest,2013,123(3):1182-1191.DOI:10.1172/JCI65963.
[31] Stamp LA,Gwynne RM,Foong JPP,et al.Optogenetic demonstration of functional innervation of mouse colon by neurons derived from transplanted neural cells[J].Gastroenterology,2017,152(6):1407-1418.DOI:10.1053/j.gastro.2017.01.005.
[32] Cooper JE,McCann CJ,Natarajan D,et al.In vivo transplantation of enteric neural crest cells into mouse gut; engraftment,functional integration and long-term safety[J].PLoS One,2016,11(1):e0147989.DOI:10.1371/journal.pone.0147989.
[33] McCann CJ,Cooper JE,Natarajan D,et al.Transplantation of enteric nervous system stem cells rescues nitric oxide synthase deficient mouse colon[J].Nat Commun,2017,8:15937.DOI:10.1038/ncomms15937.
[34] Cooper JE,Natarajan D,McCann CJ,et al.In vivo transplantation of fetal human gut-derived enteric neural crest cells[J].Neurogastroenterol Motil,2017,29(1):e12900.DOI:10.1111/nmo.12900.
[35] Lee AS,Tang C,Rao MS,et al.Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies[J].Nat Med,2013,19(8):998-1004.DOI:10.1038/nm.3267.
[36] Prokhorova TA,Harkness LM,Frandsen U,et al.Teratoma formation by human embryonic stem cells is site dependent and enhanced by the presence of Matrigel[J].Stem Cells Dev,2009,18(1):47-54.DOI:10.1089/scd.2007.0266.
[37] Li WQ,Xiang AP.Safeguarding clinical translation of pluripotent stem cells with suicide genes[J].Organogenesis,2013,9(1):34-39.DOI:10.4161/org.24317.
[38] Itakura G,Kawabata S,Ando M,et al.Fail-safe system against potential tumorigenicity after transplantation of iPSC derivatives[J].Stem Cell Reports,2017,8(3):673-684.DOI:10.1016/j.stemcr.2017.02.003.
[39] Rollo BN,Zhang DC,Stamp LA,et al.Enteric neural cells from Hirschsprung disease patients form ganglia in autologous aneuronal colon[J].Cell Mol Gastroenterol Hepatol,2016,2(1):92-109.DOI:10.1016/j.jcmgh.2015.09.007.
[40] Burns AJ,Goldstein AM,Newgreen DF,et al.White paper on guidelines concerning enteric nervous system stem cell therapy for enteric neuropathies[J].Dev Biol,2016,417(2):229-251.DOI:10.1016/j.ydbio.2016.04.001.
[41] McCann CJ,Alves MM,Brosens E,et al.Neuronal development and onset of electrical activity in the human enteric nervous system[J].Gastroenterology,2019,156(5):1483-1495.e6.DOI:10.1053/j.gastro.2018.12.020.
[42] Yeh CD,Richardson CD,Corn JE.Advances in genome editing through control of DNA repair pathways[J].Nat Cell Biol,2019,21(12):1468-1478.DOI:10.1038/s41556-019-0425-z.
[43] Anzalone AV,Randolph PB,Davis JR,et al.Search-and-replace genome editing without double-strand breaks or donor DNA[J].Nature,2019,576(7785):149-157.DOI:10.1038/s41586-019-1711-4.
[44] Ginn SL,Amaya AK,Alexander IE,et al.Gene therapy clinical trials worldwide to 2017:an update[J].J Gene Med,2018,20(5):e3015.DOI:10.1002/jgm.3015.
[45] Hacein-Bey-Abina S,Garrigue A,Wang GP,et al.Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1[J].J Clin Invest,2008,118(9):3132-3142.DOI:10.1172/JCI35700.
[46] Seimetz D,Heller K,Richter J.Approval of first CAR-Ts:have we solved all hurdles for ATMPs?[J].Cell Med,2019,11:2155179018822781.DOI:10.1177/2155179018822781.
[47] Natarajan D,Cooper J,Choudhury S,et al.Lentiviral labeling of mouse and human enteric nervous system stem cells for regenerative medicine studies[J].Neurogastroenterol Motil,2014,26(10):1513-1518.DOI:10.1111/nmo.12420.
[48] Tsai YH,Murakami N,Gariepy CE.Postnatal intestinal engraftment of prospectively selected enteric neural crest stem cells in a rat model of Hirschsprung disease[J].Neurogastroenterol Motil,2011,23(4):362-369.DOI:10.1111/j.1365-2982.2010.01656.x.
[49] Cheng LS,Hotta R,Graham HK,et al.Endoscopic delivery of enteric neural stem cells to treat Hirschsprung disease[J].Neurogastroenterol Motil,2015,27(10):1509-1514.DOI:10.1111/nmo.12635.
[50] Fujiwara N,Nakazawa-Tanaka N,Yamataka A.Animal models of Hirschsprung’s disease:state of the art in translating experimental research to the bedside[J].Eur J Pediatr Surg,2019,29(4):361-367.DOI:10.1055/s-0039-1694745.
[51] Volarevic V,Markovic BS,Gazdic M,et al.Ethical and safety issues of stem cell-based therapy[J].Int J Med Sci,2018,15(1):36-45.DOI:10.7150/ijms.21666.
[52] Brosens E,Burns AJ,Brooks AS,et al.Genetics of enteric neuropathies[J].Dev Biol,2016,417(2):198-208.DOI:10.1016/j.ydbio.2016.07.008.
[53] Widyasari A,Pavitasari WA,Dwihantoro A,et al.Functional outcomes in Hirschsprung disease patients after transabdominal Soave and Duhamel procedures[J].BMC Gastroenterol,2018,18(1):56.DOI:10.1186/s12876-018-0783-1.
相似文献/References:
[1]曹国庆 汤绍涛杨瑛李时望毛永忠王勇.腹腔镜治疗直肠乙状结肠型先天性巨结肠122例疗效分析[J].临床小儿外科杂志,2011,10(01):0.
CAO Guo qing,TANG Shao tao,YANG Ying et al..The clinical analysis of laparoscopic transanal puuthrough operation for rectosigmoild Hirschsprung disease (122 cases report).[J].Journal of Clinical Pediatric Surgery,2011,10(12):0.
[2]陆良生阮双岁毕允力陆毅群王翔葛琳娟肖现民.45例两性畸形患儿的诊断及治疗分析[J].临床小儿外科杂志,2011,10(01):0.
[3]刘鸿坚杨传民祁泳波王千于丹张晋绥张强李伟李友.经肛门改良Soave术治疗先天性巨结肠80例疗效分析[J].临床小儿外科杂志,2011,10(01):0.
[4]景登攀张根领孙蔓丽.改良Snodgrass术治疗尿道下裂疗效观察[J].临床小儿外科杂志,2011,10(01):0.
[5]许瑞江
洪锡伟
于向华
李文超.大年龄儿童发育性髋脱位术后再脱位的治疗[J].临床小儿外科杂志,2010,9(02):0.
XU Rui-jiang,HONG Xi-wei,YU Xiang-hua,et al.Surgical management for redislocation after open reduction of developmental dislocation of the hip in older children[J].Journal of Clinical Pediatric Surgery,2010,9(12):0.
[6]姜 海
汪 兵
吴永涛
苗武胜
吴 革.儿童肱骨远端骨骺分离的手术治疗[J].临床小儿外科杂志,2010,9(02):0.
Jiang hai,Wang bin,Wu yongtao,et al.The operative treatment in children’s distal humeral osteoepiphysis fracture.[J].Journal of Clinical Pediatric Surgery,2010,9(12):0.
[7]姜海吴永涛苗武胜梁晓军吴革汪兵张博皓.儿童移位型股骨颈骨折16例临床分析[J].临床小儿外科杂志,2010,9(03):0.
[8]王琪.儿童髂前上棘骨折27例疗效分析[J].临床小儿外科杂志,2010,9(03):0.
[9]王鹏高翟波罗淑颖.婴幼儿室间隔缺损合并肺动脉高压的外科治疗[J].临床小儿外科杂志,2010,9(03):0.
[10]张舰范学圣.小儿脾脏外伤保守治疗47例[J].临床小儿外科杂志,2010,9(03):0.
备注/Memo
收稿日期:2023-8-28。
基金项目:东莞市社会发展重点项目(201950715028167;20221800905372;20231800939942)
通讯作者:马达,Email:804103064@qq.com